We deliver on your promises

Helping you expedite the development of new medicines, therapies and treatments that advance human health across the globe.

Whether a pharmaceutical, biotech or medical device company, we are your ideal pan-European, full-service CRO.
Our in-depth expertise and long lasting experience combined with a flexible, and collaborative approach allow us to tailor our responses to each individual study.

Our clinical development capabilities span through trial Phases I-IV, across a broad range of therapeutic areas including medical devices.
We have an excellent track record for supporting a range of stakeholders in the pharmaceutical industry including sponsors and research institutions at each clinical development phase.

500

completed
projects

95

repeat
business

87

positive
recommendation

8

site inspections
from EMA/FDA completed

Tailor-made solutions

Your effective and rigorously compliant project strategy will be tailor-made to the specific requirements of your clinical trial. Our flexibility in project design and implementation, based on our in hours expertise and experience is backed up by delivering full-service with deep local expertise across Europe.

Your Regulatory and Operational Local Expert

You gain access to a population of more than 500 million people throughout our 24 offices in strategic locations in Europe. Currently, we’re running more than 300 active trials in 36 different countries.

Delivery focused

A proud track record of accelerated start-up timelines, over-achievement of recruitment targets, early completions and cost competitive budgetary adherence demonstrates that we are extremely focused at running efficient and effective clinical trials.

Shared goals

You need a CRO partner who is as invested in the success of each bespoke clinical trial as you are. We collaborate closely, constantly making sure that we are aligned with your study expectations and key study milestones. Essentially, we become an extended arm to your team with the same shared goals.

Pharmaceutical companies
Delivery-focused bespoke solutions for all phases of drug development.
Biotechnology enterprises
Dedicated service and expertise that delivers high-quality, cost-effective results.
Medical Device companies
Smart solutions built on a combination of regulatory expertise and deep understanding of project specificities.

News

April 13, 2022 in News

Optimapharm announces the acquisitions of CTG (Clinical Trials Group)

Optimapharm announces the acquisitions of CTG (Clinical Trials Group) We Deliver on Your Promises Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce the acquisition of CTG (Clinical Trials Group). This acquisition will…
Read More
March 30, 2022 in News

Optimapharm announces Ivana Waller as CEO of the Company

Optimapharm announces Ivana Waller as CEO On Tuesday, 29th of March, Optimapharm announced that its Board of Directors has unanimously appointed Ivana Waller as Chief Executive Officer (CEO) of the Company, effective 29th March 2022. "I have been fortunate to…
Read More
December 14, 2021 in News

Optimapharm announces the acquisitions of SSS International Clinical Research and Crown CRO

Optimapharm announces the acquisitions of SSS International Clinical Research and Crown CRO We Deliver on Your Promises Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO) that provides successful tailor-made clinical research solutions to Biotech, Pharma and…
Read More
November 29, 2021 in News

Taiga Biotechnologies important milestone

Taiga Biotechnologies important milestone Reaching a milestone Optimapharm is pleased to announce we have reached an important milestone on Taiga Biotechnologies Inc. TBX-2400-01 study initiating first site in Croatia for patients undergoing hematopoietic stem cell transplant (HSCT). #teamOptimapharm is excited…
Read More